100 related articles for article (PubMed ID: 21852479)
1. Immunology. The adjuvant effects of antibodies.
Smyth MJ; Kershaw MH
Science; 2011 Aug; 333(6045):944-5. PubMed ID: 21852479
[No Abstract] [Full Text] [Related]
2. Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies.
Li F; Ravetch JV
Science; 2011 Aug; 333(6045):1030-4. PubMed ID: 21852502
[TBL] [Abstract][Full Text] [Related]
3. [Mix-up of Fc receptors in the response to monoclonal antibodies].
Teillaud JL
Med Sci (Paris); 2012 Jan; 28(1):11-3. PubMed ID: 22289817
[No Abstract] [Full Text] [Related]
4. CD40 antibody as an adjuvant induces enhanced T cell responses.
Carlring J; Barr TA; McCormick AL; Heath AW
Vaccine; 2004 Sep; 22(25-26):3323-8. PubMed ID: 15308355
[TBL] [Abstract][Full Text] [Related]
5. Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens.
Waight JD; Chand D; Dietrich S; Gombos R; Horn T; Gonzalez AM; Manrique M; Swiech L; Morin B; Brittsan C; Tanne A; Akpeng B; Croker BA; Buell JS; Stein R; Savitsky DA; Wilson NS
Cancer Cell; 2018 Jun; 33(6):1033-1047.e5. PubMed ID: 29894690
[TBL] [Abstract][Full Text] [Related]
6. In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.
Kretz-Rommel A; Qin F; Dakappagari N; Torensma R; Faas S; Wu D; Bowdish KS
J Immunother; 2007 Oct; 30(7):715-26. PubMed ID: 17893564
[TBL] [Abstract][Full Text] [Related]
7. Fc-receptors as regulators of immunity.
Nimmerjahn F; Ravetch JV
Adv Immunol; 2007; 96():179-204. PubMed ID: 17981207
[TBL] [Abstract][Full Text] [Related]
8. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
9. Maternal immunization with ovalbumin prevents neonatal allergy development and up-regulates inhibitory receptor Fc gamma RIIB expression on B cells.
Victor JR; Muniz BP; Fusaro AE; de Brito CA; Taniguchi EF; Duarte AJ; Sato MN
BMC Immunol; 2010 Mar; 11():11. PubMed ID: 20222978
[TBL] [Abstract][Full Text] [Related]
10. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the humoral immune response by targeting CD40 and FcγRII/III; delivery of soluble but not particulate antigen to CD40 enhances antibody responses with a Th1 bias.
Szekeres Z; Herbáth M; Szittner Z; Papp K; Erdei A; Prechl J
Mol Immunol; 2011 Oct; 49(1-2):155-62. PubMed ID: 21893346
[TBL] [Abstract][Full Text] [Related]
12. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
[TBL] [Abstract][Full Text] [Related]
13. Innate myeloid cells under the control of adaptive immunity: the example of mast cells and basophils.
Daëron M
Curr Opin Immunol; 2016 Feb; 38():101-8. PubMed ID: 26745401
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity.
Russo V; Cipponi A; Raccosta L; Rainelli C; Fontana R; Maggioni D; Lunghi F; Mukenge S; Ciceri F; Bregni M; Bordignon C; Traversari C
J Clin Invest; 2007 Oct; 117(10):3087-96. PubMed ID: 17885685
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
Carmi Y; Spitzer MH; Linde IL; Burt BM; Prestwood TR; Perlman N; Davidson MG; Kenkel JA; Segal E; Pusapati GV; Bhattacharya N; Engleman EG
Nature; 2015 May; 521(7550):99-104. PubMed ID: 25924063
[TBL] [Abstract][Full Text] [Related]
16. Loading of dendritic cells with antigen in vitro or in vivo by immunotargeting can replace the need for adjuvant.
Sornasse T; Flamand V; De Becker G; Thielemans K; Urbain J; Leo O; Moser M
Adv Exp Med Biol; 1993; 329():299-303. PubMed ID: 7691032
[No Abstract] [Full Text] [Related]
17. Split peripheral tolerance: CD40 ligation blocks tolerance induction for CD8 T cells but not for CD4 T cells in response to intestinal antigens.
Chung Y; Ko SY; Ko HJ; Kang CY
Eur J Immunol; 2005 May; 35(5):1381-90. PubMed ID: 15827964
[TBL] [Abstract][Full Text] [Related]
18. Immunology. Considering therapeutic antibodies.
Vitetta ES; Ghetie VF
Science; 2006 Jul; 313(5785):308-9. PubMed ID: 16857927
[No Abstract] [Full Text] [Related]
19. Marked enhancement of antigen-specific T-cell responses by IL-7-fused nonlytic, but not lytic, Fc as a genetic adjuvant.
Nam HJ; Song MY; Choi DH; Yang SH; Jin HT; Sung YC
Eur J Immunol; 2010 Feb; 40(2):351-8. PubMed ID: 19950168
[TBL] [Abstract][Full Text] [Related]
20. CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination.
Xu H; Zhao G; Huang X; Ding Z; Wang J; Wang X; Cheng Y; Kang Y; Wang B
J Gene Med; 2010 Jan; 12(1):97-106. PubMed ID: 19950201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
